Lower risk Medical device recall · FDA · Published November 2, 2021

Magnolia Medical Steripath Gen2 Blood Collection System Recall: Premature Needle

Magnolia Medical recalls Steripath Gen2 Blood Collection Systems (21G/23G) due to premature needle retraction complaints. Affected units have specific model numbers and lot numbers listed in the recall notice.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #Z-0318-2022Medical device Magnolia Medical ›

Lower-risk recall

Due to an uptick of complaints associated with premature needle retraction of blood collection system.

Take action

Contact the company

Recalling firmMagnolia Medical Technologies, Inc.200 W Mercer St Ste 500 · Seattle, WA 98119-5908

✎ GovInfoNow plain-language explainer

Magnolia Medical is recalling its Steripath Gen2 Blood Collection Systems because users have reported premature needle retraction. This could lead to inaccurate blood tests or injury during blood draws if the needle retracts too soon. Read more at govinfonow.com/recall/61601-magnolia-medical-steripath-gen2-blood-collection-system-recall-premature-needle.

Source Summary by GovInfoNow · govinfonow.com/recall/61601-magnolia-medical-steripath-gen2-blood-collection-system-recall-premature-needle · Updated August 19, 2026 · FDA enforcement record: FDA #Z-0318-2022

Cite this page

“Magnolia Medical Steripath Gen2 Blood Collection System Recall: Premature Needle.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/61601-magnolia-medical-steripath-gen2-blood-collection-system-recall-premature-needle. Based on FDA recall #Z-0318-2022 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0318-2022%22&limit=1).

The FDA announced on 2021-11-02 that Magnolia Medical Technologies, Inc. is voluntarily recalling The Steripath Gen2 Blood Collection System due to premature needle retraction hazards. GovInfoNow's records show the recall affects 137,200 devices distributed nationwide.

How to tell if you have it

Brand: Magnolia Medical
Product: Steripath Gen2 Blood Collection System
Model Numbers: 2700-21-EN, 2700-23-EN, 27BD-21-EN, 27BD-23-EN
Lot Numbers: 9447412, 9447043, 9446903, 9447120, 9446991, 9447413, 9446807, 9447124, 5005432, 9446708, 9447121, 5005328, 9446696, 9446547, 9446994, 9447122

The hazard

The recall is due to an uptick of complaints associated with premature needle retraction of the blood collection system. The record does not report specific incidents or injuries.

Context

GovInfoNow's records show Magnolia Medical Technologies, Inc. has 1 other recall on record since 2021-08-02. Other recent recalls of similar products include B Braun Medical Blood Set Recall (2025-10-29), Siemens Healthcare Syva EMIT 2000 Quinidine Assay Recall (2026-07-13), and GVS TM SQ40S Blood Transfusion Filter Recall (2025-11-03).

How to tell if you have this one

Check for model numbers 2700-21-EN, 2700-23-EN, 27BD-21-EN, or 27BD-23-EN on the product. Affected units also have specific lot numbers listed in the recall notice.

Brand
Magnolia Medical
Category
Medical device

Based on the official FDA remedy

What to do — step by step

Check Product Details
Look for model numbers 2700-21-EN, 2700-23-EN, 27BD-21-EN, or 27BD-23-EN on the product.
Contact Manufacturer
Reach out to Magnolia Medical for further assistance if you have the affected model numbers.

Where it went and when

Where it was distributed

Distributed nationwide; the notice names 27 states.

FDA distribution: “U.S. Nationwide distribution in the states of MD, WV, DE, VA, DC, IN, MI, MA, SC, NY, IL, TX, AL, OK, GA, NE, FL, MO, CA, CO, NM, AR, WY, KS, PA, WA, MT, and AZ.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Alabama, Arizona, Arkansas, California, Colorado, Delaware, District of Columbia, Florida, Georgia, Illinois, Indiana, Kansas, Maryland, Massachusetts, Michigan, Missouri, Montana, Nebraska, New Mexico, New York, Oklahoma, Pennsylvania, South Carolina, Texas, Virginia, Washington, West Virginia, Wyoming.

Recall timeline

FDA terminated this recall 18 months after the firm started it.

Nov 2, 2021Firm started the recall
Dec 1, 2021FDA classified it Class II
Dec 8, 2021Published in FDA’s Enforcement Report
May 8, 2023FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

More Magnolia Medical recalls

Link to this recall

<a href="https://govinfonow.com/recall/61601-magnolia-medical-steripath-gen2-blood-collection-system-recall-premature-needle">Magnolia Medical Steripath Gen2 Blood Collection System Recall: Premature Needle (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #Z-0318-2022 (November 2, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0318-2022 to see it in context.
Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.